Article Information
History
- August 10, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- 1Centre for Vaccines and Immunology, National Institute for Communicable Diseases, division of the National Health Laboratory Service, Johannesburg, South Africa
- 2Department of Biomedical and Clinical Technology, Faculty of Health Sciences, Durban University of Technology, Durban, South Africa
- 3Department of Medical Virology, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
- ↵*Corresponding author E-mail: shelinam{at}nicd.ac.za